全文获取类型
收费全文 | 8723篇 |
免费 | 941篇 |
国内免费 | 175篇 |
专业分类
耳鼻咽喉 | 80篇 |
儿科学 | 79篇 |
妇产科学 | 64篇 |
基础医学 | 1573篇 |
口腔科学 | 103篇 |
临床医学 | 979篇 |
内科学 | 1911篇 |
皮肤病学 | 111篇 |
神经病学 | 979篇 |
特种医学 | 1087篇 |
外国民族医学 | 2篇 |
外科学 | 681篇 |
综合类 | 652篇 |
现状与发展 | 2篇 |
预防医学 | 397篇 |
眼科学 | 74篇 |
药学 | 348篇 |
11篇 | |
中国医学 | 60篇 |
肿瘤学 | 646篇 |
出版年
2024年 | 28篇 |
2023年 | 191篇 |
2022年 | 249篇 |
2021年 | 364篇 |
2020年 | 423篇 |
2019年 | 404篇 |
2018年 | 329篇 |
2017年 | 321篇 |
2016年 | 326篇 |
2015年 | 320篇 |
2014年 | 462篇 |
2013年 | 475篇 |
2012年 | 382篇 |
2011年 | 414篇 |
2010年 | 357篇 |
2009年 | 402篇 |
2008年 | 409篇 |
2007年 | 392篇 |
2006年 | 388篇 |
2005年 | 325篇 |
2004年 | 306篇 |
2003年 | 277篇 |
2002年 | 281篇 |
2001年 | 256篇 |
2000年 | 205篇 |
1999年 | 154篇 |
1998年 | 160篇 |
1997年 | 167篇 |
1996年 | 130篇 |
1995年 | 122篇 |
1994年 | 108篇 |
1993年 | 99篇 |
1992年 | 76篇 |
1991年 | 76篇 |
1990年 | 81篇 |
1989年 | 46篇 |
1988年 | 41篇 |
1987年 | 46篇 |
1986年 | 38篇 |
1985年 | 37篇 |
1984年 | 41篇 |
1983年 | 28篇 |
1982年 | 21篇 |
1981年 | 29篇 |
1980年 | 17篇 |
1979年 | 18篇 |
1978年 | 2篇 |
1977年 | 8篇 |
1976年 | 3篇 |
1966年 | 2篇 |
排序方式: 共有9839条查询结果,搜索用时 15 毫秒
1.
《Vaccine》2022,40(30):4038-4045
PurposeAs protection from COVID-19 following two doses of the BNT162b2 vaccine showed a time dependent waning, a third (booster) dose was administrated. This study aims to compare the antibody response following the third dose versus the second and to evaluate post-booster seroconversion.MethodsA prospective observational study conducted in Maccabi Healthcare Services. Serial SARS-CoV-2 Spike IgG tests, 1,2,3 and 6 months following the second vaccine dose and one month following the third were obtained. Neutralizing antibody levels were measured in a subset of participants. Per individual SARS-CoV-2 Spike IgG titer ratios were calculated one month after the booster administration compared to titers one month following the second dose and prior to booster.ResultsAmong 110 participants, 56 (51%) were women. Mean age was 61.7 ± 1.9 years and 66 (60%) were immunocompromised. One month after third dose, IgG titers were induced 7.83 (95 %CI 5.25–11.67) folds and 2.40 (95 %CI 1.90–3.03) folds compared to one month after the second, in the immunocompromised and immunocompetent groups, respectively. Of the 17 immunocompromised participants who were seronegative after the second dose, 4 (24%) became seropositive following the third. Comparing the titers prior to the third dose, an increase of 50.7 (95 %CI 32.5–79.1) fold in the immunocompromised group and 25.7 (95 %CI 19.1–34.7) fold in and immunocompetent group, was observed.ConclusionA third BNT162b2 vaccine elicited robust humoral response, superior to the response observed following the second, among immunocompetent and immunocompromised individuals. 相似文献
2.
3.
4.
5.
6.
《Journal of pain and symptom management》2020,59(4):794-807.e4
ContextPalliative care is gaining ground globally and is endorsed in high-level policy commitments, but service provision, supporting policies, education, and funding are incommensurate with rapidly growing needs.ObjectivesThe objective of this study was to describe current levels of global palliative care development and report on changes since 2006.MethodsAn online survey of experts in 198 countries generated 2017 data on 10 indicators of palliative care provision, fitted to six categories of development. Factor analysis and discriminant analysis showed the validity of the categorization. Spearman correlation analyses assessed the relationship with World Bank Income Level (WBIL), Human Development Index (HDI), and Universal Health Coverage (UHC).ResultsNumbers (percentages) of countries in each development category were as follows: 1) no known palliative care activity, 47 (24%); 2) capacity-building, 13 (7%); 3a) isolated provision, 65 (33%); 3b) generalized provision, 22 (11%); 4a) preliminary integration into mainstream provision, 21 (11%); 4b) advanced integration, 30 (15%). Development levels were significantly associated with WBIL (rS = 0.4785), UHC (rS = 0.5558), and HDI (rS = 0.5426) with P < 0.001. Net improvement between 2006 and 2017 saw 32 fewer countries in Categories 1/2, 16 more countries in 3a/3b, and 17 more countries in 4a/4b.ConclusionPalliative care at the highest level of provision is available for only 14% of the global population and is concentrated in European countries. An 87% global increase in serious health-related suffering amenable to palliative care interventions is predicted by 2060. With an increasing need, palliative care is not reaching the levels required by at least half of the global population. 相似文献
7.
《Clinical neurophysiology》2020,131(5):1087-1098
ObjectiveFunctional connectivity networks (FCNs) based on interictal electroencephalography (EEG) can identify pathological brain networks associated with epilepsy. FCNs are altered by interictal epileptiform discharges (IEDs), but it is unknown whether this is due to the morphology of the IED or the underlying pathological activity. Therefore, we characterized the impact of IEDs on the FCN through simulations and EEG analysis.MethodsWe introduced simulated IEDs to sleep EEG recordings of eight healthy controls and analyzed the effect of IED amplitude and rate on the FCN. We then generated FCNs based on epochs with and without IEDs and compared them to the analogous FCNs from eight subjects with infantile spasms (IS), based on 1340 visually marked IEDs. Differences in network structure and strength were assessed.ResultsIEDs in IS subjects caused increased connectivity strength but no change in network structure. In controls, simulated IEDs with physiological amplitudes and rates did not alter network strength or structure.ConclusionsIncreases in connectivity strength in IS subjects are not artifacts caused by the interictal spike waveform and may be related to the underlying pathophysiology of IS.SignificanceDynamic changes in EEG-based FCNs during IEDs may be valuable for identification of pathological networks associated with epilepsy. 相似文献
8.
Anna‐Mari Hekkala Heikki Vnnen Heikki Swan Lasse Oikarinen Matti Viitasalo Lauri Toivonen 《Annals of noninvasive electrocardiology》2006,11(4):318-326
Background: Accurate measurement of the QT interval is important for diagnosing long QT syndrome (LQTS), and in research on determinants of ventricular repolarization time. We tested automatic analysis of QT intervals from multiple ECG leads on chest. Methods: Eleven healthy volunteers and 10 genotyped LQTS patients were tested at rest and during exercise with a bicycle ergometer twice 1–31 months apart. Electrocardiograms were recorded with the body surface potential mapping system, and 12 precordial channels were selected for analysis. Averaged QT peak and QT end intervals were determined with an automated algorithm, and the difference QT end minus QT peak (Tp‐e) was calculated. Repeatability was assessed by coefficient of variation (CV) between measurements. Results: Within one test at rest the QT end intervals were highly repeatable with CV 0.6%. In repeated tests CV was 4.4% for QT end interval and 3.5% when the QT interval was corrected for heart rate. In exercise test at specified heart rates, mean CV was 3.0% for QT end and 2.9% for QT peak interval. The CV of Tp‐e interval was 10.2% at rest, and 9.3% in exercise test. Reproducibility was comparable between healthy subjects and LQTS patients. Conclusions: The BSPM system with automated analysis produced accurate and highly repeatable QT interval measurements. Reproducibility was adequate also over prolonged time periods both at rest and in exercise stress test. The method can be applied in studying duration of ventricular repolarization time in different physiologic and pharmacologic interventions. 相似文献
9.
10.